Third Annual 
Huntington Disease Clinical Research Symposium

Organized by the Huntington Study Group
Saturday, November 21, 2009
8:00a.m. - 1:30p.m.
Hyatt Regency
Baltimore, MD 21202 U.S.A.

Huntington disease (HD), a devastating disease that robs people of their mobility, intellect, and sanity, has resisted attempts at treatment since it was first recognized in 1872 as a distinct genetic ailment.  Now, some 135 years later, clinical research into treatments that might alleviate symptoms and/or modify the disease are finally producing glimmers of hope for patients and families affected by the disease.

In recognition of the emerging focus on patient-oriented research, the Huntington Study Group (HSG), comprised of clinical investigators from the United States, Europe, and Australia, will convene the Third Annual Huntington Disease Clinical Research Symposium, to be held on Saturday morning, November 21, 2009 at the Hyatt Regency on the Inner Harbor in Baltimore, Maryland. 

The Symposium will feature keynote addresses by:

• Judy Roberson, HD Community Member 
• Jan Nolta, PhD, a researcher from University of California, Davis, who will speak on the development of stem cell research for HD 
• Celia Witten, FDA representative from the Center for Biologics Evaluation and Research, to talk about the regulation of stem cell research   

In addition to these keynote addresses, clinical scientists will be presenting their original research on relevant topics of interest to the HD community today.

The symposium is open to the HD community, the public and the press. Pre-registration by November 9th is free. On-site registration is $25.00 and is payable by cash or check at the event.